Root Jonathan D's Form 4 filing
ARS Pharmaceuticals, Inc. (SPRY) · filed Mar 18, 2022
- Accession no.
- 0001062993-22-008141
- Filed
- Mar 18, 2022
- Trade date
- Mar 3-Nov 15, 2021
- Filing delay
- 380 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $36.0K. It was filed 380 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Root Jonathan DCIK 0001225480 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2021 | Common Stock | PPurchaseAcquired | +350 | $52.07 | +$18,224.5 | 350 | Indirect | |
| Nov 15, 2021 | Common Stock | PPurchaseAcquired | +2,014 | $8.85 | +$17,823.9 | 2,364 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.